Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on

Inotiv, a US CRO specialising in nonclinical and analytical drug discovery and development services, has

AlzChem, the only supplier of speciality nitriles outside China, has completed a €12 million expansion

Merck KGaA is to spend €59 million to expand HPAPI and ADC manufacturing capabilities and

Mark Quick, EVP of  corporate development at Recipharm, discusses the M&A trend within the CDMO